Safety, Tolerability and Pharmacokinetics of Tafenoquine After Weekly and Escalating Monthly Doses of Tafenoquine in Healthy Vietnamese Volunteers
Latest Information Update: 03 Apr 2024
At a glance
- Drugs Tafenoquine (Primary)
- Indications Babesiosis; COVID 2019 infections; Malaria; Pneumocystis pneumonia
- Focus Adverse reactions
Most Recent Events
- 08 Apr 2022 Planned initiation date changed from 10 Feb 2022 to 10 May 2022.
- 28 Jan 2022 New trial record